These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25564456)

  • 1. Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis.
    Schlesinger M; Bendas G
    Cancer Metastasis Rev; 2015 Dec; 34(4):575-91. PubMed ID: 25564456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding between heparin and the integrin VLA-4.
    Schlesinger M; Simonis D; Schmitz P; Fritzsche J; Bendas G
    Thromb Haemost; 2009 Nov; 102(5):816-22. PubMed ID: 19888514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity very late antigen-4 subsets expressed on T cells are mandatory for spontaneous adhesion strengthening but not for rolling on VCAM-1 in shear flow.
    Chen C; Mobley JL; Dwir O; Shimron F; Grabovsky V; Lobb RR; Shimizu Y; Alon R
    J Immunol; 1999 Jan; 162(2):1084-95. PubMed ID: 9916737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyr61 is a target for heparin in reducing MV3 melanoma cell adhesion and migration via the integrin VLA-4.
    Schmitz P; Gerber U; Schütze N; Jüngel E; Blaheta R; Naggi A; Torri G; Bendas G
    Thromb Haemost; 2013 Nov; 110(5):1046-54. PubMed ID: 24009013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular cell adhesion molecule-1 (VCAM-1)--an increasing insight into its role in tumorigenicity and metastasis.
    Schlesinger M; Bendas G
    Int J Cancer; 2015 Jun; 136(11):2504-14. PubMed ID: 24771582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic Tumor VCAM-1 Expression in Cancer Metastasis and Therapy Resistance.
    VanHeyst KA; Choi SH; Kingsley DT; Huang AY
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers.
    Klemke M; Weschenfelder T; Konstandin MH; Samstag Y
    J Cell Physiol; 2007 Aug; 212(2):368-74. PubMed ID: 17352405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives.
    Schlesinger M; Schmitz P; Zeisig R; Naggi A; Torri G; Casu B; Bendas G
    Thromb Res; 2012 May; 129(5):603-10. PubMed ID: 22099706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD81 tetraspanin facilitates instantaneous leukocyte VLA-4 adhesion strengthening to vascular cell adhesion molecule 1 (VCAM-1) under shear flow.
    Feigelson SW; Grabovsky V; Shamri R; Levy S; Alon R
    J Biol Chem; 2003 Dec; 278(51):51203-12. PubMed ID: 14532283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).
    Wang HS; Hung Y; Su CH; Peng ST; Guo YJ; Lai MC; Liu CY; Hsu JW
    Exp Cell Res; 2005 Mar; 304(1):116-26. PubMed ID: 15707579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches.
    Fritzsche J; Simonis D; Bendas G
    Thromb Haemost; 2008 Dec; 100(6):1166-75. PubMed ID: 19132244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand binding of leukocyte integrin very late antigen-4 involves exposure of sulfhydryl groups and is subject to redox modulation.
    Liu SY; Tsai MY; Chuang KP; Huang YF; Shieh CC
    Eur J Immunol; 2008 Feb; 38(2):410-23. PubMed ID: 18196516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VLA-4 blockade suppresses endotoxin-induced uveitis: in vivo evidence for functional integrin up-regulation.
    Hafezi-Moghadam A; Noda K; Almulki L; Iliaki EF; Poulaki V; Thomas KL; Nakazawa T; Hisatomi T; Miller JW; Gragoudas ES
    FASEB J; 2007 Feb; 21(2):464-74. PubMed ID: 17202250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin.
    Schlesinger M; Roblek M; Ortmann K; Naggi A; Torri G; Borsig L; Bendas G
    Thromb Res; 2014 May; 133(5):855-62. PubMed ID: 24636486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha4beta1 integrin (VLA-4) blockade attenuates both early and late leukocyte recruitment and neointimal growth following carotid injury in apolipoprotein E (-/-) mice.
    Barringhaus KG; Phillips JW; Thatte JS; Sanders JM; Czarnik AC; Bennett DK; Ley KF; Sarembock IJ
    J Vasc Res; 2004; 41(3):252-60. PubMed ID: 15153775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes.
    Garmy-Susini B; Avraamides CJ; Desgrosellier JS; Schmid MC; Foubert P; Ellies LG; Lowy AM; Blair SL; Vandenberg SR; Datnow B; Wang HY; Cheresh DA; Varner J
    Proc Natl Acad Sci U S A; 2013 May; 110(22):9042-7. PubMed ID: 23671068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-α enhanced fusions between oral squamous cell carcinoma cells and endothelial cells via VCAM-1/VLA-4 pathway.
    Song K; Zhu F; Zhang HZ; Shang ZJ
    Exp Cell Res; 2012 Aug; 318(14):1707-15. PubMed ID: 22664325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immobilized stromal cell-derived factor-1alpha triggers rapid VLA-4 affinity increases to stabilize lymphocyte tethers on VCAM-1 and subsequently initiate firm adhesion.
    DiVietro JA; Brown DC; Sklar LA; Larson RS; Lawrence MB
    J Immunol; 2007 Mar; 178(6):3903-11. PubMed ID: 17339490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer metastasis: Putative therapeutic role of vascular cell adhesion molecule-1.
    Sharma R; Sharma R; Khaket TP; Dutta C; Chakraborty B; Mukherjee TK
    Cell Oncol (Dordr); 2017 Jun; 40(3):199-208. PubMed ID: 28534212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4.
    Okigami H; Takeshita K; Tajimi M; Komura H; Albers M; Lehmann TE; Rölle T; Bacon KB
    Eur J Pharmacol; 2007 Mar; 559(2-3):202-9. PubMed ID: 17234179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.